ArticleFrontiers in cardiovascular medicine2026
Application of predicting risk of cardiovascular disease events equations on postoperative major adverse cardiac and cerebral events for patients undergoing thoracic surgery.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The American Heart Association's Predicting Risk of Cardiovascular Disease Events (PREVENT) equations predict cardiovascular risk, but their utility in perioperative settings is unclear. This study aims to evaluate the association between PREVENT equations and postoperative cardiovascular events in thoracic surgical population. Methods: This retrospective study included 1,073 patients undergoing thoracic surgery at Nanfang Hospital, Southern Medical University, between January 2019 and October 2023. The sex-specific PREVENT risk scores for atherosclerotic cardiovascular disease (ASCVD), coronary heart disease (CHD), heart failure (HF), and total cardiovascular disease (CVD) were calculated. The study outcome was 30-day postoperative composite events of major adverse cardiac and cerebral events (MACCE: composite of angina, myocardial injury, stroke, and HF). The single event or composition combinations matched to PREVENT risk scores were also assessed: angina, HF, angina or myocardial injury (AMI), AMI or stroke (AMIS). Multivariate logistic regression was used to evaluate MACCE risk, with false discovery rate (FDR) correction for Results: The median age of included patients was 58 years old. In females, one standard-deviation (SD) increase in the ASCVD score was significantly associated with higher odds of postoperative angina (OR = 1.95, 95% CI: 1.19-3.21, FDR corrected Conclusions: The PREVENT equations demonstrated preliminary associations with 30-day postoperative MACCE in non-cardiac thoracic surgical female patients, but not in male patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.